ArcticZymes is pleased to announce the approval of a new Chairman of the Board and two new Directors. As stated by the new Chairman, Dr. Mathias, who is CEO of Oxford Biomedica, “I am honored to join ArcticZymes at such a pivotal time. The innovative enzyme solutions developed by ArcticZymes have made significant contributions to advancements in biomanufacturing, enhancing efficiency and quality across the industry. I look forward to contributing to the company’s continued success and collaborative growth.” For the complete press release, visit: https://lnkd.in/dXJ8ZhTH Dr. Frank Mathias Sharon Brownlow Petter Dragesund #pharmaceuticalmanufacturing #molecularresearch #diagnostics #biomanufacturing #EnzymeTechnology
ArcticZymes Technologies ASA
Bioteknologisk forskning
Tromsø, Troms 5,845 følgere
ArcticZymes Technologies is a life sciences company focused on premium and novel enzymes
Om oss
ArcticZymes Technologies ASA (OSE: AZT) is a global leader in supplying best-in-class enzyme technologies to commercial partners who develop therapeutics, in vitro diagnostics, and molecular research kit products. Our mission is to make our customers lives easier by unlocking new solutions to enhance quality of life and create a more sustainable healthy world. We provide our customers with cold-adapted enzymes from the arctic environment with unique features including heat lability and activity in challenging environments, as well as, customised engineered novel features which can be easily integrated to fuel their innovations. For more information, please visit www.arcticzymes.com
- Nettsted
-
http://www.arcticzymes.com
Ekstern lenke til ArcticZymes Technologies ASA
- Bransje
- Bioteknologisk forskning
- Bedriftsstørrelse
- 51–200 ansatte
- Hovedkontor
- Tromsø, Troms
- Type
- Åpent aksjeselskap
- Grunnlagt
- 1990
- Spesialiteter
- Novel cold-adapted enzymes, High-quality enzymes, Custom enzymes, B2B, OEM, Life Sciences, Pharma Services, CDMO
Beliggenheter
-
Primær
Sykehusvegen
Tromsø, Troms 9019, NO
-
987 Old Eagle School Rd
Wayne, Pennsylvania 19087, US
Ansatte i ArcticZymes Technologies ASA
-
Michael Benjamin Akoh
Life Science Executive | CEO | Strategy | P&L | Leadership | Commercialization
-
Jeremy Gillespie
VP Corporate Development @ ArcticZymes | Accelerating Biotech Technologies
-
Børge Sørvoll
CFO at ArcticZymes Technologies ASA
-
Sharon Brownlow
Biotech and cell and gene therapy industry commercial leader
Oppdateringer
-
Joint Webinar with acib GmbH presenting new data about how chromatin affects your bioprocessing> https://lnkd.in/dfvwgZWy For maximum #dnaclearing of your #viralvectors and #bioprocessing this our SAN nucleases are a #paradigmshift for #genetherapy #therapeutics #bioprocessing #vaccines #oncolyticviruses #lentivirus #adenoassociatedvirus #AAV
View Link to Joint Webinar with acib
-
Join scientists presenting from ACIB & ArcticZymes, the inventors of salt active nucleases, on Sep 19th for this webinar to understand solutions to a problem that may go under the radar with many viral vector manufacturers. Uncover how to elevate yield and purity and streamline DSP with reduced cost— if it sounds "too good to be true," we are only quoting a top-tier gene therapy company that told us that. Embrace innovation from the source itself - Register today! https://lnkd.in/dfvwgZWy #dnaclearing #viralvectors #bioprocessing #genetherapy #therapeutics #vaccines #bioprocessing #oncolyticviruses #lentivirus #cdmo
-
-
Couldn't attend today's presentation at Handelsbanken's Small & Mid Cap Seminar 2024? We have you covered. See the presentation from CEO Michael Akoh and CFO Børge Sørvoll with the link to PDF on our 2024 Reports & Finance page here: https://lnkd.in/emE7aSdG
-
Register for the webinar, but only if the "WHAT YOU'LL LEARN" bullets resonate with you. Check it out now! https://lnkd.in/dfvwgZWy Discover critical insights about DNA vs. Chromatin that could transform your bioprocessing workflow. #dnaclearing #viralvectors #bioprocessing #genetherapy #therapeutics #vaccines #bioprocessing #oncolyticviruses #chromatin
-
-
Missed the Live Session about Clearing DNA from #ViralVectors and Optimizing #Bioprocessing? Come by #433 to GET HIGHLIGHTS and learn how to ⬆ Purity and ⬇ Costs with this salt active nuclease #dnaclearing #genetherapy #therapeutics #vaccines #oncolyticviruses #ASGCT2024 #ASGCT https://lnkd.in/d3HBktVQ
-
-
How can you be at #ASGCT2024 and not meet the #Inventors of the technology revolutionizing #bioprocessing? 🚀 You've likely heard of Salt Active Nucleases for DNA clearance from #ViralVectors #OncolyticViruses & #vaccines 🧬 Now meet the pioneers and let's talk science & solutions! Visit us at #ASGCT and unlock the insights your research deserves! https://lnkd.in/d3HBktVQ
-
-
Join ArcticZymes Technologies live presentation of Q1 2024 results at 08:30 CET on May 8th. The presentation will be given by CEO Michael Akoh and CFO Børge Sørvoll. Link to the Live Webcast is on our news page: https://lnkd.in/d4kFuqGN
-
The one gold nugget you're looking to take home from #asgct. This is it - if you're doing #bioprocessing or currently using Benzonase. For maximum #dnaclearing of your #viralvectors #oncolyticviruses and #vaccines this is a #paradigmshift for #genetherapy and #therapeutics. #asgct2024. Craving a pinch of wisdom? 🧂✨Book a meeting in the event app, or here https://lnkd.in/ddh4gSYh
-
For maximum #dnaclearing of your #viralvectors #oncolyticviruses and #vaccines this is a #paradigmshift for #genetherapy and #therapeutics. Pencil in this talk at #asgct2024. Craving a pinch of wisdom? 🧂✨ Send your questions to the inventors of salt active nucleases https://lnkd.in/d3HBktVQ